HemOnc Today New York

Healio.com brings you the highlights from HemOnc Today New York. Refer back to this page often to read the latest news, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.
Meeting News

Standards evolve for adjuvant therapy of melanoma

March 21, 2019
NEW YORK — A strong rationale exists for offering adjuvant therapy to certain patients with melanoma, but several aspects of treatment remain…
Meeting News

More immunotherapy regimens ‘desperately needed’ for salvage treatment of advanced NSCLC

March 21, 2019
NEW YORK — Results of the KEYNOTE-189 trial dramatically altered initial treatment for patients with advanced-stage non-small cell lung cancer…
Meeting News

Immunotherapy-chemotherapy combination should be first-line treatment for many patients with NSCLC

March 21, 2019
NEW YORK — A combination of immunotherapy and chemotherapy should be used as first line treatment for many patients with non-small cell lung…
Meeting News

Lung cancer ‘personifies precision medicine’

March 21, 2019
NEW YORK — Precision medicine approaches have dramatically altered treatment approaches and improved outcomes for patients with lung cancer…
Meeting News

HemOnc Today New York uses ‘practical, interactive approach’ to help providers improve cancer care

March 6, 2019
HemOnc Today is pleased to announce plans for a 3-day CME meeting designed to offer expert perspectives on advances in cancer treatment. …
Meeting News

BRAF/MEK inhibitor therapy a preferred option for metastatic melanoma

March 26, 2018
NEW YORK — Combination therapy with BRAF and MEK inhibitors can confer long-term survival for patients with low-burden metastatic melanoma and…
Meeting NewsVideo

VIDEO: CAR T cells effective for non-Hodgkin lymphoma

March 13, 2018
NEW YORK — In this video commentary from HemOnc Today New York, Stephen J. Schuster, MD, discusses treatment with CD19-directed chimeric…
Meeting NewsVideo

VIDEO: Meeting offers insights into application of CAR T-cell therapy for hematologic malignancies

March 12, 2018
NEW YORK — In this video commentary from HemOnc Today New York, program co-chair David L. Porter, MD, discusses some of the take-home messages…
Meeting News

CAR T-cell therapy holds promise for multiple myeloma

March 12, 2018
NEW YORK — Cellular immunotherapies such as chimeric antigen receptor therapy are a promising approach for treatment of multiple myeloma…
Meeting News

Targeted therapies effective for acute lymphoblastic leukemia

March 10, 2018
NEW YORK — Targeted therapies such as inotuzumab and blinatumomab appear associated with high rates of complete molecular remission in patients…